FWP
IBB icon

FAS Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

FAS Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
13,419
-356
-3% -$61.2K 0.13% 129
2026
Q1 		$2.33M Sell
13,775
-339
-2% -$58K 0.14% 122
2025
Q4 		$2.38M Sell
14,114
-169
-1% -$27.4K 0.15% 117
2025
Q3 		$2.06M Sell
14,283
-696
-5% -$95K 0.14% 124
2025
Q2 		$1.89M Sell
14,979
-3,517
-19% -$432K 0.14% 123
2025
Q1 		$2.37M Sell
18,496
-876
-5% -$119K 0.19% 106
2024
Q4 		$2.56M Sell
19,372
-2,977
-13% -$419K 0.22% 99
2024
Q3 		$3.25M Sell
22,349
-588
-3% -$85.1K 0.26% 86
2024
Q2 		$3.15M Sell
22,937
-530
-2% -$70.8K 0.27% 80
2024
Q1 		$3.22M Sell
23,467
-115
-0.5% -$15.7K 0.29% 80
2023
Q4 		$3.2M Sell
23,582
-1,874
-7% -$229K 0.3% 75
2023
Q3 		$3.11M Buy
25,456
+755
+3% +$96K 0.33% 67
2023
Q2 		$3.14M Buy
24,701
+241
+1% +$31.3K 0.4% 60
2023
Q1 		$3.16M Buy
24,460
+2,003
+9% +$262K 0.34% 63
2022
Q4 		$2.95M Buy
22,457
+2,106
+10% +$272K 0.33% 69
2022
Q3 		$2.38M Buy
20,351
+1,769
+10% +$220K 0.26% 61
2022
Q2 		$2.19M Buy
18,582
+550
+3% +$65.3K 0.23% 73
2022
Q1 		$2.35M Buy
18,032
+456
+3% +$59.4K 0.22% 71
2021
Q4 		$2.68M Sell
17,576
-770
-4% -$119K 0.25% 64
2021
Q3 		$2.97M Sell
18,346
-307
-2% -$51.7K 0.28% 56
2021
Q2 		$3.05M Sell
18,653
-520
-3% -$80.1K 0.29% 56
2021
Q1 		$2.89M Sell
19,173
-1,867
-9% -$297K 0.3% 58
2020
Q4 		$3.19M Buy
21,040
+686
+3% +$98K 0.36% 51
2020
Q3 		$2.76M Buy
20,354
+350
+2% +$47.5K 0.38% 49
2020
Q2 		$2.73M Sell
20,004
-642
-3% -$81.8K 0.4% 50
2020
Q1 		$2.22M Buy
20,646
+20,377
+7,575% +$2.35M 0.39% 52
2019
Q4 		$32K Buy
+269
New +$30K 0.01% 243

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

FAS Wealth Partners's IBB Position: Q2 2026 in Review

FAS Wealth Partners reduced its iShares Biotechnology ETF (IBB) stake by 2.6% in Q2 2026, selling an estimated $61.2K and leaving 13,419 shares worth $2.55M. The position accounts for 0.13% of the portfolio, ranked #129.

FAS Wealth Partners first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.25M in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • FAS Wealth Partners held 13,419 shares of iShares Biotechnology ETF worth $2.55M as of Q2 2026.
  • FAS Wealth Partners sold 356 iShares Biotechnology ETF shares in Q2 2026, an estimated $61.2K.
  • iShares Biotechnology ETF made up 0.13% of FAS Wealth Partners's portfolio in Q2 2026, its #129 holding.
  • FAS Wealth Partners first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • FAS Wealth Partners's iShares Biotechnology ETF position peaked at $3.25M in Q3 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.